A Study of LY3127804 With Ramucirumab in Participants With Advanced Solid Tumors
Clinical trial NCT02597036 · TERMINATED
Trial details
- NCT number
- NCT02597036
- Sponsor
- Eli Lilly and Company
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-06
- Primary completion
- 2017-11-23
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.